Original Article
Prevalence of Diabetes among Men and Women in China
N Engl J Med 2010; 362:1090-1101March 25, 2010
- Abstract
Background
Because of the rapid change in lifestyle in China, there is concern that diabetes may become epidemic. We conducted a national study from June 2007 through May 2008 to estimate the prevalence of diabetes among Chinese adults.
Methods
A nationally representative sample of 46,239 adults, 20 years of age or older, from 14 provinces and municipalities participated in the study. After an overnight fast, participants underwent an oral glucose-tolerance test, and fasting and 2-hour glucose levels were measured to identify undiagnosed diabetes and prediabetes (i.e., impaired fasting glucose or impaired glucose tolerance). Previously diagnosed diabetes was determined on the basis of self-report.
Results
The age-standardized prevalences of total diabetes (which included both previously diagnosed diabetes and previously undiagnosed diabetes) and prediabetes were 9.7% (10.6% among men and 8.8% among women) and 15.5% (16.1% among men and 14.9% among women), respectively, accounting for 92.4 million adults with diabetes (50.2 million men and 42.2 million women) and 148.2 million adults with prediabetes (76.1 million men and 72.1 million women). The prevalence of diabetes increased with increasing age (3.2%, 11.5%, and 20.4% among persons who were 20 to 39, 40 to 59, and ≥60 years of age, respectively) and with increasing weight (4.5%, 7.6%, 12.8%, and 18.5% among persons with a body-mass index [the weight in kilograms divided by the square of the height in meters] of <18.5, 18.5 to 24.9, 25.0 to 29.9, and ≥30.0, respectively). The prevalence of diabetes was higher among urban residents than among rural residents (11.4% vs. 8.2%). The prevalence of isolated impaired glucose tolerance was higher than that of isolated impaired fasting glucose (11.0% vs. 3.2% among men and 10.9% vs. 2.2% among women).
Conclusions
These results indicate that diabetes has become a major public health problem in China and that strategies aimed at the prevention and treatment of diabetes are needed.
Media in This Article
Figure 1
Age-Specific Prevalences of Diabetes and Prediabetes among Chinese Adults 20 Years of Age or Older.Figure 2
Prevalences of Diabetes and Prediabetes and Absolute Numbers of Cases among Chinese Adults 20 Years of Age or Older, According to Urban or Rural Residence.Article Activity
- Article
Cardiovascular disease has become the leading cause of death in China, a development that has followed rapid economic growth, an increase in life expectancy, and changes in lifestyle.1 Diabetes is a major risk factor for cardiovascular disease, and the prevalence of diabetes is high and is increasing in China.2-4 A national survey conducted in 1994, involving 224,251 Chinese residents, 25 to 64 years of age, from 19 provinces, showed that the prevalences of diabetes and impaired glucose tolerance were 2.5% and 3.2%, respectively.2 These estimates were higher by a factor of approximately 3 than those reported in 1980.3 In a cross-sectional study in 2000–2001 involving a nationally representative sample of 15,540 adults, 35 to 74 years of age, the prevalences of diabetes and impaired fasting glucose were 5.5% and 7.3%, respectively.4 Although these studies have documented a marked increase in the prevalence of diabetes in China, they cannot be compared directly, owing to methodologic differences in sampling and to differences in the criteria used to define diabetes.2-4 Furthermore, the prevalences of diabetes and prediabetes were probably underestimated in these studies because 2-hour oral glucose-tolerance tests were not performed in all participants. It has been suggested that isolated hyperglycemia 2 hours after glucose loading is common among Asian patients with diabetes.5 For example, in the Shanghai Diabetes Study, 48.6% of patients with newly diagnosed diabetes had isolated hyperglycemia 2 hours after glucose loading, and 75.0% of those with prediabetes had isolated impaired glucose tolerance.6
The China National Diabetes and Metabolic Disorders Study, conducted from June 2007 through May 2008, was a cross-sectional study designed to provide current and reliable data on the prevalences of diabetes and associated metabolic risk factors in the adult population in China.
Methods
Study Participants
We used a multistage, stratified sampling method to select a nationally representative sample of persons 20 years of age or older in the general population. The sampling process was stratified according to geographic region (northeast, north, east, south central, northwest, and southwest China), degree of urbanization (large cities [Beijing, Shanghai, and provincial capitals], midsize cities, county seats, and rural townships), and economic development status (as assessed on the basis of the gross domestic product [GDP] for each province). The first two stages of sampling, in which provinces were selected from geographic regions and cities and counties were selected from provinces, were not random. In the next two stages (the stage in which city districts were selected from cities and rural townships from counties and the stage in which street districts were selected from city districts and rural villages from townships), the sampling was random (see Figure 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org). This multistage, stratified sampling process resulted in an oversampling of urban residents. In total, 152 urban street districts and 112 rural villages were selected. In the final stage of sampling, the sample was stratified according to the sex and age distribution in China, on the basis of Chinese population data from 2006.7 Only persons who had lived in their current residence for 5 years or longer were eligible to participate.
A total of 54,240 people were selected and invited to participate in the study; 47,325 persons (18,976 men and 28,349 women) completed the study. The overall response rate was 87.3%: 81.0% for men and 92.0% for women; 88.1% of those who lived in urban areas and 82.7% of those who lived in rural areas responded. After the exclusion of 538 persons for whom demographic information was missing and 548 for whom data on fasting or 2-hour plasma glucose levels were missing, 46,239 adults were included in the final analysis.
The institutional review board or ethics committee at each participating institution approved the study protocol. Written informed consent was obtained from each participant before data collection.
Data Collection
A standard questionnaire was administered by trained staff to obtain information on demographic characteristics, personal and family medical history, and lifestyle risk factors.8 The interview included questions related to the diagnosis and treatment of diabetes, hypertension, dyslipidemia, and cardiovascular events. Cigarette smoking was defined as having smoked at least 100 cigarettes in one's lifetime. Information was obtained on the amount and type of alcohol that was consumed during the previous year, and alcohol drinking was defined as the consumption of at least 30 g of alcohol per week for 1 year or more. Regular leisure-time physical activity was defined as participation in moderate or vigorous activity for 30 minutes or more per day at least 3 days a week. Socioeconomic status, educational level, occupation, and income were also recorded. The economic development of provinces or municipalities was defined on the basis of the GDP per capita in 2006. Blood pressure, body weight, height, and waist circumference were measured with the use of standard methods, as described previously.2
All study investigators and staff members successfully completed a training program that familiarized them with both the aims of the study and the specific tools and methods used. At the training sessions, interviewers were given detailed instructions concerning the administration of the study questionnaire. Clinical staff members were trained to measure blood pressure and obtain anthropometric measurements and blood specimens according to a standard protocol.8
Oral Glucose-Tolerance Test
Participants were instructed to maintain their usual physical activity and diet for at least 3 days before the oral glucose-tolerance test. After at least 10 hours of overnight fasting, a venous blood specimen was collected in a vacuum tube containing sodium fluoride, for the measurement of plasma glucose. Participants with no history of diabetes were given a standard 75-g glucose solution, whereas for safety reasons, participants with a self-reported history of diabetes were given a steamed bun that contained approximately 80 g of complex carbohydrates. Blood samples were drawn at 0, 30, and 120 minutes after the glucose or carbohydrate load to measure glucose concentrations. Plasma glucose was measured with the use of a hexokinase enzymatic method, and serum cholesterol and triglyceride levels were assessed enzymatically with the use of commercially available reagents, at the clinical biochemical laboratories in each province. All the study laboratories successfully completed a standardization and certification program.
Study-Outcome Definitions
The 1999 World Health Organization diagnostic criteria were used to diagnose diabetes.9 Results of plasma glucose testing were categorized as follows: isolated impaired fasting glucose (fasting glucose level, ≥110 mg per deciliter [6.1 mmol per liter] and <126 mg per deciliter [7.0 mmol per liter), and 2-hour glucose level in the glucose-tolerance test, <140 mg per deciliter [7.8 mmol per liter]), isolated impaired glucose tolerance (fasting glucose level, <110 mg per deciliter, and 2-hour glucose level, ≥140 and <200 mg per deciliter [11.1 mmol per liter]), combined impaired fasting glucose and impaired glucose tolerance (fasting glucose level, ≥110 and <126 mg per deciliter, and 2-hour glucose level, ≥140 and <200 mg per deciliter), and undiagnosed diabetes (fasting glucose level, ≥126 mg per deciliter, 2-hour glucose level, ≥200 mg per deciliter, or both). Previously diagnosed diabetes was identified by a positive response from the participant to the question, “Has a doctor ever told you that you have diabetes?” Among participants with previously diagnosed diabetes, 81.2% were using insulin or oral hypoglycemic agents and 14.9% were using lifestyle intervention alone (diet, regular exercise, or both). Total diabetes included both previously diagnosed diabetes and previously undiagnosed diabetes. Prediabetes was defined as either impaired fasting glucose or impaired glucose tolerance.
Statistical Analysis
Our study was designed to provide accurate estimates of the prevalence of diabetes according to age, sex, urban or rural residence, and level of economic development in the general Chinese population of persons 20 years of age or older. Sample sizes were estimated to meet generally recommended requirements for precision in a complex survey design.10 All calculations were weighted to represent the total population of Chinese adults (20 years of age or older) on the basis of Chinese population data from 2006 and the study sampling scheme, and were corrected for several features of the survey, including oversampling for female and urban residents, nonresponse, highly developed economic regions, and other demographic or geographic differences between the sample and the total population.
Mean values for lifestyle and metabolic factors were determined according to sex and plasma glucose categories. Prevalence estimates for diabetes and prediabetes were calculated for the overall population and for subgroups according to age, sex, and other variables. Age- and sex-standardized prevalences were calculated by the direct method with the use of data on the population distribution in China in 2006.7 Estimated numbers of persons with diabetes and prediabetes were calculated from subgroup-specific prevalences according to age, sex, geographic region, urban or rural residence, and level of economic development and from data on the size of the population in China in 2006. A multinomial logit analysis was used to examine the association of demographic, lifestyle, and metabolic factors with the odds of diabetes and prediabetes. With the use of backward elimination, only covariables that were significant (P<0.05) were retained in the final model. Standard errors were calculated with the use of a technique that was appropriate to the complex survey design. All P values are two-tailed and have not been adjusted for multiple testing. All statistical analyses were conducted with the use of SUDAAN software, version 10 (Research Triangle Institute).
Results
Prevalences of Diabetes and Prediabetes
The prevalences of isolated impaired fasting glucose, isolated impaired glucose tolerance, combined impaired fasting glucose and impaired glucose tolerance, previously undiagnosed diabetes, and previously diagnosed diabetes were 3.2%, 11.0%, 1.9%, 6.5%, and 4.1% among men and 2.2%, 10.9%, 1.7%, 5.2%, and 3.5% among women, respectively (Table 1Table 1
Characteristics of Study Participants According to Plasma Glucose Categories and Sex.). The prevalence of undiagnosed diabetes in which the 2-hour plasma glucose level in an oral glucose-tolerance test was 200 mg per deciliter or more but the fasting glucose level was less than 126 mg per deciliter was 2.9% among men and 2.6% among women. In other words, 46.6% of the participants with undiagnosed diabetes (44.1% of the men and 50.2% of the women) had isolated increased 2-hour plasma glucose levels after an oral glucose-tolerance test. In the case of approximately 61.3% of the men with diabetes and 59.8% of the women with diabetes, the diabetes had not previously been diagnosed. In general, patients with previously diagnosed diabetes had higher fasting plasma glucose levels and higher 2-hour plasma glucose levels in an oral glucose-tolerance test than did those with undiagnosed diabetes. In addition, patients with previously diagnosed diabetes, as compared with those with undiagnosed diabetes, were older, more likely to have a family history of diabetes, more likely to participate in leisure-time physical activity, less likely to smoke cigarettes, and less likely to be obese. A total of 70.7% of the participants with prediabetes (68.3% of the men and 73.6% of the women) had isolated impaired glucose tolerance, and participants with isolated impaired glucose tolerance were slightly older than those who had isolated impaired fasting glucose. In addition, women with isolated impaired glucose tolerance had a higher body-mass index, higher systolic blood pressure, and higher serum triglyceride levels than did women with isolated impaired fasting glucose.The overall prevalences of total diabetes (previously diagnosed plus previously undiagnosed diabetes) and prediabetes were 9.7% and 15.5%, respectively. The age-specific prevalences of diabetes and prediabetes increased significantly with increasing age (P<0.001 for both comparisons) (Figure 1Figure 1
Age-Specific Prevalences of Diabetes and Prediabetes among Chinese Adults 20 Years of Age or Older.). The age-standardized prevalence of diabetes was significantly higher among men than among women (P<0.001), but the age-standardized prevalence of prediabetes did not differ significantly according to sex (P=0.08). The age-standardized prevalence of diabetes was significantly higher among urban residents than among rural residents (11.4% vs. 8.2%, P<0.001) (Figure 2Figure 2Prevalences of Diabetes and Prediabetes and Absolute Numbers of Cases among Chinese Adults 20 Years of Age or Older, According to Urban or Rural Residence.); however, the age-standardized prevalence of prediabetes was slightly lower among urban residents than among rural residents (14.9% vs. 16.0%, P=0.06).Metabolic Risk Factors
The age-adjusted mean fasting glucose level, body-mass index, waist circumference, serum triglyceride level, and systolic blood pressure were significantly higher in men than in women, whereas the high-density lipoprotein (HDL) cholesterol level was lower in men than in women (Table 2Table 2
Age- and Sex-Standardized Prevalences of Diabetes and Prediabetes and Mean Values of Metabolic Risk Factors in the Overall Cohort and in Subgroups.). The sex-adjusted fasting glucose level, 2-hour glucose level in an oral glucose-tolerance test, body-mass index, waist circumference, HDL cholesterol level, triglyceride level, and systolic blood pressure all increased significantly with increasing age. The age- and sex-adjusted prevalences of diabetes and prediabetes, as well as the mean fasting glucose level, 2-hour glucose level in the oral glucose-tolerance test, waist circumference, serum triglyceride level, and systolic blood pressure, increased significantly, whereas the HDL cholesterol level decreased, with increasing body-mass index.Economic Development and Urbanization
In the economically developed regions, the age- and sex-adjusted prevalence of diabetes did not differ significantly between urban and rural residents, whereas the prevalence of prediabetes was higher among rural residents. In the intermediately developed and underdeveloped regions, the prevalence of diabetes and levels of metabolic risk factors were higher among urban residents than among rural residents.
In 2007–2008, it was estimated that among adults 20 years of age or older in China, there were 92.4 million persons with diabetes (50.2 million men and 42.2 million women) and 148.2 million persons with prediabetes (76.1 million men and 72.1 million women). An estimated 49.3 million persons with diabetes lived in urban areas, and 43.1 million in rural areas (Figure 2); an estimated 64.7 million persons with prediabetes lived in urban areas, and 83.5 million in rural areas.
Multivariable Risk Assessment
In the multivariable, multinomial, logit models, male sex, older age, a family history of diabetes, overweight, obesity, central obesity, increased heart rate, elevated systolic blood pressure, elevated serum triglyceride level, educational level below college, and urban residence were all significantly associated with an increased risk of diabetes (Table 3Table 3
Multivariable-Adjusted Odds Ratios for Diabetes and Prediabetes.). In addition, older age, a family history of diabetes, overweight, obesity, central obesity, increased heart rate, elevated systolic blood pressure, elevated serum triglyceride level, and educational level below college were significantly associated with an increased risk of prediabetes, whereas there was a marginally significant association between urban residence and a decreased risk of prediabetes.Discussion
Our results indicate that diabetes has reached epidemic proportions in the general adult population in China. Overall, 92.4 million adults 20 years of age or older (9.7% of the adult population) have diabetes, and in 60.7% of these cases, the diabetes is undiagnosed. In addition, 148.2 million adults (15.5%) have prediabetes, which is an important risk factor for the development of overt diabetes and cardiovascular disease.11,12 These findings, which are based on a large population-based study involving a nationally representative sample of Chinese adults, should provide an accurate estimate of the diabetes and prediabetes burden in China. In addition, the diagnosis of diabetes was established on the basis of both fasting plasma glucose levels and 2-hour plasma glucose levels in an oral glucose-tolerance test, and these measurements were obtained with the use of stringent quality-control procedures.
Diabetes increases the risk of microvascular and macrovascular complications and premature death in the general population and results in a huge economic burden for society.13-17 Randomized clinical trials have shown that interventions involving diet and exercise reduce the risk of diabetes among people with prediabetes.18-20 Public health measures should be undertaken to mitigate the consequences of new cases of diabetes.
Several previous national or regional studies have documented a rapid increase in the prevalence of diabetes in the Chinese adult population.2-4,6,21 However, in those studies, oral glucose-tolerance tests were not performed in the entire study population or in a random sample2-4; therefore, the true prevalence of undiagnosed diabetes may have been underestimated. In the present study, 46.6% of the cases of undiagnosed diabetes and 70.7% of the cases of prediabetes met the criteria for elevated 2-hour plasma glucose levels in an oral glucose-tolerance test but not the criteria for elevated fasting glucose levels. Qiao and colleagues found that in a pooled analysis of Asian cohorts, more than half the subjects with diabetes had isolated hyperglycemia after glucose loading and three quarters of the subjects with prediabetes had isolated impaired glucose tolerance.5 Even accounting for differences in diagnostic criteria, our study documents a large increase in the prevalences of previously diagnosed diabetes, previously undiagnosed diabetes, and prediabetes. The aging of the population, urbanization, nutritional changes, and decreasing levels of physical activity, with a consequent epidemic of obesity, have probably contributed to the rapid increase in the diabetes burden in the Chinese population.21-23 Future studies are needed to examine the relative contributions of individual risk factors to the increased prevalence of diabetes in the Chinese population.
A higher prevalence of diabetes among urban residents than among rural residents has been observed in developing countries throughout the world.2-4,16,17,24,25 Urbanization is associated with changes in lifestyle that lead to physical inactivity, an unhealthful diet, and obesity, all of which have been implicated as contributing factors in the development of diabetes.26-28 In our study, both overall obesity and central obesity were strongly associated with increased prevalences of diabetes and prediabetes. In the analysis stratified according to the level of economic development, the prevalence of diabetes was similar between urban residents and rural residents in economically developed regions but differed between these groups in intermediately developed and underdeveloped regions. Our analysis suggests that the level of economic development and associated lifestyle and diet may explain the differences in the prevalence of diabetes between persons who live in urban settings and those who live in rural areas.
Like previous studies,29,30 our study showed a significant inverse association between educational level and the prevalence of diabetes. Educational level is a good indicator of socioeconomic status, and a higher educational level has been associated with lower levels of cardiovascular risk factors, such as obesity, dyslipidemia, and hypertension.31,32
Our study has several limitations. First, women and urban residents were oversampled, and there was a lower response rate among men than among women. We took these issues into account when we calculated statistical weights. However, the response rate was higher than 80% among men, and potential selection bias due to nonresponse should be minimal. Second, dietary intake and work-related physical activity were not assessed in our study. Therefore, we were not able to determine the association between these factors and the prevalence of diabetes. Third, to ensure comparability across studies, we used the World Health Organization criteria to define diabetes and prediabetes in our study. The relationship of glucose categories to the risk of microvascular and macrovascular diseases, however, has not been extensively examined in the Chinese population.20,33
In summary, our results show that diabetes and prediabetes are highly prevalent in the general adult population in China. Given its large population, China may bear a higher diabetes-related burden than any other country.16,17 More troublesome is the finding that the majority of cases of diabetes are undiagnosed. These results indicate that diabetes has become a major public health challenge in China and underscore the need for national strategies aimed at the prevention, detection, and treatment of diabetes in the general Chinese population.
Supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society.
No potential conflict of interest relevant to this article was reported.
Source Information
From China–Japan Friendship Hospital, Beijing (W.Y., J.X.); Chinese People's Liberation Army General Hospital, Beijing (J. Lu); Sun Yat-sen University Third Hospital, Guangzhou (J.W.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai (W.J.); Peking University People's Hospital, Beijing (L.J.); First Affiliated Hospital, Chinese Medical University, Liaoling (Z.S.); Shanxi Province People's Hospital, Taiyuan, Shaanxi (J. Liu); West China Hospital, Sichuan University, Chengdu, Sichuan (H.T.); Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi (Q.J.); Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu (D.Z.); Xinjiang Uygur Autonomous Region's Hospital, Urmqi, Xinjiang (J.G.); Fujian Provincial Hospital, Fuzhou, Fujiang (L.L.); Qilu Hospital, Qilu Hospital of Shandong University, Jinan, Shandong (L.C.); Peking University First Hospital, Beijing (X.G.); Henan Province People's Hospital, Zhengzhou, Henan (Z. Zhao); Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang (Q.L.); Xiangya Second Hospital, Changsha, Hunan (Z. Zhou); and Peking Union Medical College, Beijing (G.S.) — all in China; and Tulane University School of Public Health and Tropical Medicine, New Orleans (J.H.).
Address reprint requests to Dr. Yang at the Department of Endocrinology, China–Japan Friendship Hospital, Beijing 100029, China, or at ywy_1010@yahoo.com.cn.
The members of the China National Diabetes and Metabolic Disorders Study group are listed in the Supplementary Appendix, available with the full text of this article at NEJM.org.
- References
References
1
He J ,Gu D ,Wu X , et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124-1134
Full Text | Web of Science | Medline2
Pan XR ,Yang WY ,Li GW ,Liu J . Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care 1997;20:1664-1669
CrossRef | Web of Science | Medline3
National Diabetes Research Group 4
Gu D ,Reynolds K ,Duan X , et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003;46:1190-1198
CrossRef | Web of Science | Medline5
Qiao Q ,Nakagami T ,Tuomilehto J , et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000;43:1470-1475
CrossRef | Web of Science | Medline6
Jia WP ,Pang C ,Chen L , et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 2007;50:286-292
CrossRef | Web of Science | Medline7
National Bureau of Statistics of China. China statistical yearbook — 2006. Beijing: China Statistics Press, 2006. (Accessed February 26, 2010, at http://www.stats.gov.cn/tjsj/ndsj/2006/indexeh.htm.)
8
Luepker RV, Evans A, McKeigue P, Reddy KS. Cardiovascular survey methods. 3rd ed. Geneva: World Health Organization, 2004.
9
Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999. (Accessed February 26, 2010, at http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf.)
10
Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94
Medline11
Schmidt MI ,Duncan BB ,Bang H , et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005;28:2013-2018
CrossRef | Web of Science | Medline12
Levitzky YS ,Pencina MJ ,D'Agostino RB , et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008;51:264-270
CrossRef | Web of Science | Medline13
Haffner SM ,Lehto S ,Ronnemaa T ,Pyorala K ,Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234
Full Text | Web of Science | Medline14
Schramm TK ,Gislason GH ,Kober L , et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008;117:1945-1954
CrossRef | Web of Science | Medline15
Brancati FL ,Whelton PK ,Randall BL ,Neaton JD ,Stamler J ,Klag MJ . Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT: Multiple Risk Factor Intervention Trial. JAMA 1997;278:2069-2074
CrossRef | Web of Science | Medline16
Wild S ,Roglic G ,Green A ,Sicree R ,King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
CrossRef | Web of Science | Medline17
Diabetes atlas. 3rd ed. Brussels: International Diabetes Federation, 2008. (Accessed February 26, 2010, at http://www.eatlas.idf.org/index-2.html.)
18
Tuomilehto J ,Lindstrom J ,Eriksson JG , et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
Full Text | Web of Science | Medline19
Diabetes Prevention Program Research Group
Full Text | Web of Science | Medline20
Li G ,Zhang P ,Wang J , et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783-1789
CrossRef | Web of Science | Medline21
Li G ,Hu Y ,Pan X . Prevalence and incidence of NIDDM in Daqing City. Chin Med J (Engl) 1996;109:599-602
Web of Science | Medline22
Leeder S, Raymond S, Greenberg H, Liu H, Esson K. A race against time: the challenge of cardiovascular disease in developing economies. New York: Columbia University, 2004.
23
Yang G ,Kong L ,Zhao W , et al. Emergence of chronic non-communicable diseases in China. Lancet 2008;372:1697-1705
CrossRef | Web of Science | Medline24
Wang Y ,Mi J ,Shan XY ,Wang QJ ,Ge KY . Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 2007;31:177-188
CrossRef | Web of Science | Medline25
Singh RB ,Bajaj S ,Niaz MA ,Rastogi SS ,Moshiri M . Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol 1998;66:65-72
CrossRef | Web of Science | Medline26
Reynolds K ,Gu D ,Whelton PK , et al. Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring) 2007;15:10-18
CrossRef | Web of Science | Medline27
Muntner P ,Gu D ,Wildman RP , et al. Prevalence of physical activity among Chinese adults: results from the International Collaborative Study of Cardiovascular Disease in Asia. Am J Public Health 2005;95:1631-1636
CrossRef | Web of Science | Medline28
Li LM ,Rao KQ ,Kong LZ , et al. A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26:478-484
Medline29
Borrell LN ,Dallo FJ ,White K . Education and diabetes in a racially and ethnically diverse population. Am J Public Health 2006;96:1637-1642
CrossRef | Web of Science | Medline30
Ko GTC ,Chan JCN ,Yeung VT ,Chow CC ,Tsang LW ,Cockram CS . A low socio-economic status is an additional risk factor for glucose intolerance in high risk Hong Kong Chinese. Eur J Epidemiol 2001;17:289-295
CrossRef | Web of Science | Medline31
Seeman T ,Merkin SS ,Crimmins E ,Koretz B ,Charette S ,Karlamangla A . Education, income and ethnic differences in cumulative biological risk profiles in a national sample of US adults: NHANES III (1988-1994). Soc Sci Med 2008;66:72-87
CrossRef | Web of Science | Medline32
Yan LL ,Liu K ,Daviglus ML , et al. Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study. JAMA 2006;295:1793-1800
CrossRef | Web of Science | Medline33
Chan JC ,Malik V ,Jia W , et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140
CrossRef | Web of Science | Medline
- Citing Articles (132)
Citing Articles
1
Shi Lin Lin, So Lun Lee, Lai Ling Hui, Shiu Lun Au Yeung, Michael A. Tse, Gabriel M. Leung, C. Mary. Schooling. (2012) Pubertal muscle mass and diabetes markers in chinese adolescents. American Journal of Human Biology 24:2, 183-185
CrossRef2
Yinghua Lin, Yuan Xu, Gang Chen, Xiaolan Lai, Baoying Huang, Zichun Chen, Longteng Yao, Shaoheng Zhu, Jin Yao, Junping Wen, Huibin Huang, Caijing Lin. (2012) Diabetes and Its Chronic Complications in the She Ethnic Minority Group of China. Diabetes Technology & Therapeutics120203064223009
CrossRef3
Wen Huang, Hongbo Ren, Qiwen Ben, Quancai Cai, Wei Zhu, Zhaoshen Li. (2012) Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. Cancer Causes & Control 23:2, 263-272
CrossRef4
Dong Zhao, Fan Zhao, Yan Li, Zheng Zheng. (2012) Projected and Observed Diabetes Epidemics in China and Beyond. Current Cardiology Reports 14:1, 106-111
CrossRef5
Y. Bi, L. Zeng, D. Zhu, J. Yan, Y. Zhang, G. Tong, P. Mu, S. Shen, Y. Hu, Q. Yu, H. Liang, J. Weng. (2012) Association of β-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population. Diabetes, Obesity and Metabolism 14:2, 174-180
CrossRef6
Xin Wang, Ling Tao, Chun X. Hai. (2012) Redox-regulating role of insulin: The essence of insulin effect. Molecular and Cellular Endocrinology 349:2, 111-127
CrossRef7
Yue Liu, Ke-ji Chen. (2012) Atherosclerosis, vascular aging and therapeutic strategies. Chinese Journal of Integrative Medicine 18:2, 83-87
CrossRef8
Gui-Ke Zou, Ying-Liang Song, Wei Zhou, Miao Yu, Li-Hua Liang, Dao-Cai Sun, De-Hua Li, Zai-Xi Deng, Wen-Zhong Zhu. (2012) Effects of local delivery of bFGF from PLGA microspheres on osseointegration around implants in diabetic rats. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
CrossRef9
(2012) Panretinal Photocoagulation for Diabetic Retinopathy. New England Journal of Medicine 366:3, 277-279
Full Text10
Z.-J. Yang, J. Liu, J.-P. Ge, L. Chen, Z.-G. Zhao, W.-Y. Yang, . (2012) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. European Heart Journal 33:2, 213-220
CrossRef11
Satish K. Garg. (2012) Rising Epidemic of Diabetes and Hypertension in Asia. Diabetes Technology & Therapeutics 14:1, 1-2
CrossRef12
Jia Shen, Abhinav Goyal, Laurence Sperling. (2012) The Emerging Epidemic of Obesity, Diabetes, and the Metabolic Syndrome in China. Cardiology Research and Practice 2012, 1-5
CrossRef13
Longyi Zeng, Hongyun Lu, Hongrong Deng, Panwei Mu, Xiaofeng Li, Manman Wang. (2012) Noninferiority Effects on Glycemic Control and β-Cell Function Improvement in Newly Diagnosed Type 2 Diabetes Patients: Basal Insulin Monotherapy Versus Continuous Subcutaneous Insulin Infusion Treatment. Diabetes Technology & Therapeutics 14:1, 35-42
CrossRef14
Chern-En Chiang, Shu Zhang, Hung Fat Tse, Wee Siong Teo, Razali Omar, Charn Sriratanasathavorn. (2012) Atrial fibrillation management in Asia: From the Asian expert forum on atrial fibrillation. International Journal of Cardiology
CrossRef15
Jichun Yang, Yunfeng Zhou, Youfei Guan. (2012) PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases. Current Opinion in Nephrology and Hypertension 21:1, 97-105
CrossRef16
Wayne H.-H. Sheu, Li-Nong Ji, Wannee Nitiyanant, Sei Hyun Baik, Donald Yin, Panagiotis Mavros, Siew-Pheng Chan. (2012) Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region. Diabetes Research and Clinical Practice
CrossRef17
Zhongqun Wang, Yicheng Jiang, Naifeng Liu, Liqun Ren, Yinghong Zhu, Yanli An, Dengyu Chen. (2012) Advanced glycation end-product Nɛ-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes. Atherosclerosis
CrossRef18
Tsung O. Cheng. (2012) Cardiovascular health, risks and diseases in contemporary China. International Journal of Cardiology 154:2, 233-242
CrossRef19
Shaoqing Lei, Yanan Liu, Huimin Liu, Hong Yu, Hui Wang, Zhengyuan Xia. (2012) Effects of N-Acetylcysteine on Nicotinamide Dinucleotide Phosphate Oxidase Activation and Antioxidant Status in Heart, Lung, Liver and Kidney in Streptozotocin-Induced Diabetic Rats. Yonsei Medical Journal 53:2, 294
CrossRef20
Brittany A. Rasmussen, Danna M. Breen, Ping Luo, Grace W.C. Cheung, Clair S. Yang, Biying Sun, Andrea Kokorovic, Weifang Rong, Tony K.T. Lam. (2012) Duodenal Activation of cAMP-Dependent Protein Kinase Induces Vagal Afferent Firing and Lowers Glucose Production in Rats. Gastroenterology
CrossRef21
David R. Whiting, Leonor Guariguata, Clara Weil, Jonathan Shaw. (2011) IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 94:3, 311-321
CrossRef22
S. Garg, T. Bailey, T. DeLuzio, D. Pollom. (2011) Preference for a new prefilled insulin pen compared with the original pen. Current Medical Research and Opinion 27:12, 2323-2333
CrossRef23
Weiqing Wang, Ruifang Bu, Qing Su, Jianying Liu, Guang Ning. (2011) Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy. Expert Opinion on Pharmacotherapy 12:18, 2791-2799
CrossRef24
S. K. H. Wong, A. P. S. Kong, W. Y. So, B. Y. S. Tsung, P. Y. P. Yau, J. C. N. Chan, E. K. W. Ng. (2011) Use of laparoscopic sleeve gastrectomy and adjustable gastric banding for suboptimally controlled diabetes in Hong Kong. Diabetes, Obesity and Metabolismno-no
CrossRef25
Zhi-Yin Yang, Zhen Yang, Lifang Zhu, Chengxuan Qiu. (2011) Human Behaviors Determine Health: Strategic Thoughts on the Prevention of Chronic Non-communicable Diseases in China. International Journal of Behavioral Medicine 18:4, 295-301
CrossRef26
Yong Zhao, Zhaoshun Jiang, Chengshan Guo. (2011) New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells. Autoimmunity Reviews 11:2, 137-142
CrossRef27
Qingqing Lou, Liaofang Wu, Xia Dai, Meijuan Cao, Yu Ruan. (2011) Diabetes education in mainland China—A systematic review of the literature. Patient Education and Counseling 85:3, 336-347
CrossRef28
Lei Chen, Dianna J. Magliano, Paul Z. Zimmet. (2011) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nature Reviews Endocrinology
CrossRef29
Ping Zeng, Xuefeng Zhu, Yi Zhang, Shu Wang, Tiemei Zhang. (2011) Metabolic syndrome and the development of type 2 diabetes among professionals living in Beijing, China. Diabetes Research and Clinical Practice 94:2, 299-304
CrossRef30
Ralf Altmeyer. (2011) Global Biotech goes China - Institut Pasteur Shanghai launches a unique platform for global biotech companies in China. Biotechnology Journal 6:11, 1303-1304
CrossRef31
Mohammad Zubair, Abida Malik, Jamal Ahmad. (2011) Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital. The Foot
CrossRef32
Tsung O. Cheng. (2011) Cardiovascular health, risks and diseases in contemporary China. International Journal of Cardiology 152:3, 285-294
CrossRef33
Mingqing Huang, Youliang Xie, Lidian Chen, Kedan Chu, Shuisheng Wu, Jinjian Lu, Xiuping Chen, Yitao Wang, Xiaoping Lai. (2011) Antidiabetic Effect of the Total Polyphenolic Acids Fraction from Salvia miltiorrhiza Bunge in Diabetic Rats. Phytotherapy Researchn/a-n/a
CrossRef34
Wenying Yang, Chang Yu Pan, Conrad Tou, June Zhao, Ingrid Gause-Nilsson. (2011) Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial. Diabetes Research and Clinical Practice 94:2, 217-224
CrossRef35
Sen He, Xiaoping Chen, Kaijun Cui, Yong Peng, Kai Liu, Zhengbing Lv, Rui Yang, Xiaoyan Zhou. (2011) Validity evaluation of recently published diabetes risk scoring models in a general Chinese population. Diabetes Research and Clinical Practice
CrossRef36
Horng-Yih Ou, Yi-Ching Yang, Hung-Tsung Wu, Jin-Shang Wu, Feng-Hwa Lu, Chih-Jen Chang. (2011) Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clinical Endocrinology 75:4, 450-455
CrossRef37
Juliana C.N. Chan, Siew Pheng Chan, Chaicharn Deerochanawong, Ruby T. Go, Kok-Onn Lee, Ronald Ching-Wan Ma, Chang-Yu Pan, Wayne H-H. Sheu, Philip Barter. (2011) Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: What we know and don’t know. Diabetes Research and Clinical Practice 94:1, 1-13
CrossRef38
Xianhao Jia, Qin Liang, Fanglu Chi, Wenjun Cao. (2011) Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycosesno-no
CrossRef39
Weiping Jia. (2011) What have we learnt from genetic studies of type 2 diabetes in Chinese?. Journal of Diabetes Investigation 2:5, 331-332
CrossRef40
Zhi-Hua Feng, Yuan-Shan Wang, Yu-Guo Zheng. (2011) A new microtiter plate-based screening method for microorganisms producing Alpha-amylase inhibitors. Biotechnology and Bioprocess Engineering 16:5, 894-900
CrossRef41
Yan Wang, Xin Xin, Zhendong Jin, Yan Hu, Xianhui Li, Jianzhao Wu, Manwen Jin. (2011) Anti-diabetic effects of pentamethylquercetin in neonatally streptozotocin-induced diabetic rats. European Journal of Pharmacology 668:1-2, 347-353
CrossRef42
Jian-jun Dong, Neng-jun Lou, Jia-jun Zhao, Zhong-wen Zhang, Lu-lu Qiu, Ying Zhou, Lin Liao. (2011) Evaluation of a risk factor scoring model in screening for undiagnosed diabetes in China population. Journal of Zhejiang University SCIENCE B 12:10, 846-852
CrossRef43
Yi-Ming Mu, Anoop Misra, John M.F. Adam, Siew Pheng Chan, Francis C.C. Chow, Elaine Cheeay Cunanan, Chaicharn Deerochanawong, Hak Chul Jang, Nguyen Thy Khue, Wayne H.-H. Sheu, Kevin E.K. Tan. (2011) Managing diabetes in Asia: Overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Research and Clinical Practice
CrossRef44
Zhaoyan Gu, Yingzhen Du, Yu Liu, Lichao Ma, Lin Li, Yanping Gong, Hui Tian, Chunlin Li. (2011) Effect of aging on islet beta-cell function and its mechanisms in Wistar rats. AGE
CrossRef45
Qiaohui Qian, Xu Li, Bo Feng. (2011) Impact of hypertension, overall obesity and abdominal obesity on diabetes incidence in Shanghai residents with different glucose levels. Diabetes Research and Clinical Practice
CrossRef46
Dan-Tong Zhao, Hui-Yu Liao, Yan-Min Liu, Yan Zhao, Xia Feng, Hui-Ping Yan. (2011) Prognostic Factors and Survival Analysis of Antimitochondrial Antibody-Positive Primary Biliary Cirrhosis in Chinese Patients. Digestive Diseases and Sciences 56:9, 2750-2757
CrossRef47
Xin Mou, Wen-hong Liu, Dan-yang Zhou, Ying-hui Liu, Yong-bin Hu, Guo-ling Ma, Cheng-min Shou, Jia-wei Chen, Jin-xi Zhao. (2011) Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-β1 (T869C) gene polymorphism. Chinese Journal of Integrative Medicine 17:9, 680-684
CrossRef48
Shih-Tzer TSAI, Faruque PATHAN, Linong JI, Vincent Tok Fai YEUNG, Manoj CHADHA, Ketut SUASTIKA, Hyun Shik SON, Kevin Eng Kiat TAN, Yupin BENJASURATWONG, Thy Khue NGUYEN, Farrukh IQBAL. (2011) First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia. Journal of Diabetes 3:3, 208-216
CrossRef49
Hui Dong, Fu’er Lu, Nan Wang, Xin Zou, Jingjing Rao. (2011) Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities. Frontiers of Medicine 5:3, 288-293
CrossRef50
Chunwei Ye, Xiaojuan Li, Yu Wang, Yuying Zhang, Mengyin Cai, Baoyi Zhu, Panwei Mu, Xuan Xia, Yi Zhao, Jianping Weng, Xin Gao, Xingqiao Wen. (2011) Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate. Laboratory Investigation 91:9, 1363-1374
CrossRef51
Chun-Ming Ma, Fu-Zai Yin, Rui Wang, Chun-Mei Qin, Bo Liu, Dong-Hui Lou, Qiang Lu. (2011) Glycemic Variability in Abdominally Obese Men With Normal Glucose Tolerance as Assessed by Continuous Glucose Monitoring System. Obesity 19:8, 1616-1622
CrossRef52
Henry Greenberg, Susan U. Raymond, Stephen R. Leeder. (2011) The Prevention of Global Chronic Disease: Academic Public Health's New Frontier. American Journal of Public Health 101:8, 1386-1390
CrossRef53
Dong-Ming Shen, Songnian Lin, Emma R Parmee. (2011) A survey of small molecule glucagon receptor antagonists from recent patents (2006 – 2010). Expert Opinion on Therapeutic Patents 21:8, 1211-1240
CrossRef54
Wan-Ling Lin, Wei-Wei Su, Xue-Ying Cai, Lv-Keng Luo, Pei-Bo Li, Yong-Gang Wang. (2011) Fermentation effects of oligosaccharides of Radix Ophiopogonis on alloxan-induced diabetes in mice. International Journal of Biological Macromolecules 49:2, 194-200
CrossRef55
Nikolaos Papanas, Aaron I. Vinik, Dan Ziegler. (2011) Neuropathy in prediabetes: does the clock start ticking early?. Nature Reviews Endocrinology 7:11, 682-690
CrossRef56
Chandrakant Ankolekar, Kalidas Shetty. 2011. Fermentation-Based Processing of Food Botanicals for Mobilization of Phenolic Phytochemicals for Type 2 Diabetes Management. , 341-355.
CrossRef57
Tianjie Li, Xiaopan Wu, Xilin Zhu, Jingyun Li, Liping Pan, Pengtao Li, Zhenhui Xin, Ying Liu. (2011) Association analyses between the genetic polymorphisms of HNF4A and FOXO1 genes and Chinese Han patients with type 2 diabetes. Molecular and Cellular Biochemistry 353:1-2, 259-265
CrossRef58
Xiang Li, Ting Xiao, Yuzhen Wang, Hongbin Gu, Zhiguo Liu, Yufeng Jiang, Yanjun Liu, Zuqian Lu, Xiaopin Yang, Yin Lan, Zhangrong Xu. (2011) Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Research and Clinical Practice 93:1, 26-30
CrossRef59
George Dailey. (2011) Rapid-acting insulin glulisine: an update on clinical experience. Expert Review of Endocrinology & Metabolism 6:4, 527-542
CrossRef60
Ping Zhu, Chuan Yang, Li-Hong Chen, Meng Ren, Guo-juan Lao, Li Yan. (2011) Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA. Archives of Dermatological Research 303:5, 339-350
CrossRef61
Nikolaos Papanas, Niki Katsiki, Apostolos I Hatzitolios, Efstratios Maltezos. (2011) Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 12:10, 1457-1461
CrossRef62
Yoriko Heianza, Shigeko Hara, Yasuji Arase, Kazumi Saito, Kazuya Fujiwara, Hiroshi Tsuji, Satoru Kodama, Shiun Dong Hsieh, Yasumichi Mori, Hitoshi Shimano, Nobuhiro Yamada, Kinori Kosaka, Hirohito Sone. (2011) HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. The Lancet 378:9786, 147-155
CrossRef63
J. B. Echouffo-Tcheugui, M. K. Ali, S. J. Griffin, K. M. V. Narayan. (2011) Screening for Type 2 Diabetes and Dysglycemia. Epidemiologic Reviews 33:1, 63-87
CrossRef64
Xiao Yun Bao, Bin Peng, Mao Sheng Yang. (2011) Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals. Molecular Biology Reports
CrossRef65
Zhi-jia ZHANG, Shen QU. (2011) Na+-glucose cotransporter inhibitor for treatment of diabetes. Academic Journal of Second Military Medical University 31:4, 435-438
CrossRef66
Hong-Bo Ren, Tao Yu, Chao Liu, Yan-Qing Li. (2011) Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes & Control 22:6, 837-847
CrossRef67
Christian Herder, Michael Roden. (2011) Genetics of type 2 diabetes: pathophysiologic and clinical relevance. European Journal of Clinical Investigation 41:6, 679-692
CrossRef68
Wen-Yuan Lin, F. Xaiver Pi-Sunyer, Ching-Chu Chen, Lance E. Davidson, Chiu-Shong Liu, Tsai-Chung Li, Mei-Fong Wu, Chia-Ing Li, Walter Chen, Cheng-Chieh Lin. (2011) Coffee consumption is inversely associated with type 2 diabetes in Chinese. European Journal of Clinical Investigation 41:6, 659-666
CrossRef69
Xin Wang, Zhao Wang, Jiang Z. Liu, Jun X. Hu, Hong L. Chen, Wen L. Li, Chun X. Hai. (2011) Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. Toxicology in Vitro 25:4, 839-847
CrossRef70
Fang Chai, Yong Wang, Yong Zhou, Yuan Liu, Donghua Geng, Jingang Liu. (2011) Adiponectin Downregulates Hyperglycemia and Reduces Pancreatic Islet Apoptosis After Roux-En-Y Gastric Bypass Surgery. Obesity Surgery 21:6, 768-773
CrossRef71
Paula H Palmer, Bin Xie, Liming Lee, Chih-Ping Chou, Ping Sun, Bree Hemingway, C. Anderson Johnson. (2011) The China Seven Cities Study (CSCS) consortium: adapting evidence-based prevention science from west to east. Translational Behavioral Medicine 1:2, 283-288
CrossRef72
Juliana C. N. Chan, Wingyee So, Ronald C. W. Ma, Peter C. Y. Tong, Rebecca Wong, Xilin Yang. (2011) The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry. Current Cardiovascular Risk Reports 5:3, 230-239
CrossRef73
Yue Qi, Jing Liu, Wei Wang, Miao Wang, Jia-yi Sun, Jun Liu, Yan Li, Zhao-su Wu, Dong Zhao. (2011) The HindIII polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults. Clinica Chimica Acta 412:13-14, 1229-1233
CrossRef74
Wayne H.-H. Sheu, Azhari Rosman, Ambrish Mithal, Namsik Chung, Yean Teng Lim, Chaicharn Deerochanawong, Pradana Soewondo, Moon-Kyu Lee, Kun-Ho Yoon, Oliver Schnell. (2011) Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: An Asian-Pacific perspective and expert recommendations. Diabetes Research and Clinical Practice 92:3, 312-321
CrossRef75
Tony K T Lam. (2011) China needs to boost funding for graduate students to stay competitive. Nature Medicine 17:6, 655-655
CrossRef76
Yan-Hui Lu, Ju-Ming Lu, Shu-Yu Wang, Chun-Lin Li, Run-Ping Zheng, Hui Tian, Xian-Ling Wang. (2011) Outcome of intensive integrated intervention in participants with impaired glucose regulation in China. Advances in Therapy 28:6, 511-519
CrossRef77
Wing-Yee SO, Josephine RABOCA, Leorino SOBREPENA, Kun-Ho YOON, Chaicharn DEEROCHANAWONG, Low-Tone HO, Thep HIMATHONGKAM, Peter TONG, Greg LYUBOMIRSKY, Gary KO, Hairong NAN, Juliana CHAN, . (2011) Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program*. Journal of Diabetes 3:2, 109-118
CrossRef78
F. Zhang, L. Dong, C.P. Zhang, B. Li, J. Wen, W. Gao, S. Sun, F. Lv, H. Tian, J. Tuomilehto, L. Qi, C. L. Zhang, Z. Yu, X. Yang, G. Hu. (2011) Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabetic Medicine 28:6, 652-657
CrossRef79
Lal B. Rawal, Robyn J. Tapp, Emily D. Williams, Carina Chan, Shajahan Yasin, Brian Oldenburg. (2011) Prevention of Type 2 Diabetes and Its Complications in Developing Countries: A Review. International Journal of Behavioral Medicine
CrossRef80
M. Uusitupa, J. Tuomilehto, P. Puska. (2011) Are we really active in the prevention of obesity and type 2 diabetes at the community level?. Nutrition, Metabolism and Cardiovascular Diseases 21:5, 380-389
CrossRef81
Baqiyyah Conway, Yong-Bing Xiang, Raquel Villegas, Xianglan Zhang, Honglan Li, Xiaoyan Wu, Gong Yang, Yu-Tang Gao, Wei Zhang, Xiao-Ou Shu. (2011) Hip Circumference and the Risk of Type 2 Diabetes in Middle-Aged and Elderly Men and Women: The Shanghai Women and Shanghai Men’s Health Studies. Annals of Epidemiology 21:5, 358-366
CrossRef82
C. M. Y. Lee, S. Colagiuri, M. Ezzati, M. Woodward. (2011) The burden of cardiovascular disease associated with high body mass index in the Asia-Pacific region. Obesity Reviews 12:5, e454-e459
CrossRef83
Zhaoxia Jia, Yong Zhou, Xiurong Liu, Yilong Wang, Xingquan Zhao, Yongjun Wang, Wannian Liang, Shouling Wu. (2011) Comparison of different anthropometric measures as predictors of diabetes incidence in a Chinese population. Diabetes Research and Clinical Practice 92:2, 265-271
CrossRef84
Tsung O. Cheng. (2011) Diabetes epidemic in China and its economic impact. International Journal of Cardiology 149:1, 1-3
CrossRef85
Min Liu, Changyu Pan, Mengmeng Jin. (2011) A Chinese Diabetes Risk Score for Screening of Undiagnosed Diabetes and Abnormal Glucose Tolerance. Diabetes Technology & Therapeutics 13:5, 501-507
CrossRef86
-Wei Du Hong, -Yue Li Jia, He Yao. (2011) Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis. Journal of Geriatric Cardiology 8:1, 24-30
CrossRef87
Xu-hong Hou, Yun-xia Zhu, Hui-juan Lu, Hui-fen Chen, Qiang Li, Shan Jiang, Kun-san Xiang, Wei-ping Jia. (2011) Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. Journal of Gastroenterology and Hepatology 26:4, 722-730
CrossRef88
Shao-Yuan Chuang, Wen-Ting Yeh, Yi-Lin Wu, Hsing-Yi Chang, Wen-Harn Pan, Chwen-Keng Tsao. (2011) Prediction equations and point system derived from large-scale health check-up data for estimating diabetic risk in the Chinese population of Taiwan. Diabetes Research and Clinical Practice 92:1, 128-136
CrossRef89
Stephen Colagiuri. (2011) Epidemiology of Prediabetes. Medical Clinics of North America 95:2, 299-307
CrossRef90
Yufeng Jiang, Sha Huang, Xiaobing Fu, Hongwei Liu, Xingwu Ran, Shuliang Lu, Dahai Hu, Qiang Li, Hongwei Zhang, Ying Li, Runxiu Wang, Ting Xie, Biao Cheng, Lingfeng Wang, Yi Liu, Xiangbai Ye, Chunmao Han, Huade Chen. (2011) Epidemiology of chronic cutaneous wounds in China. Wound Repair and Regeneration 19:2, 181-188
CrossRef91
Ranhua Jiang, Zhibo Han, Guangsheng Zhuo, Xiaodan Qu, Xue Li, Xin Wang, Yuankang Shao, Shimin Yang, Zhong Chao Han. (2011) Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Frontiers of Medicine 5:1, 94-100
CrossRef92
Zisun Kim, Kyung Yul Hur. (2011) Laparoscopic Mini-gastric Bypass for Type 2 Diabetes: The Preliminary Report. World Journal of Surgery 35:3, 631-636
CrossRef93
Yali Jing, Dalong Zhu, Yan Bi, Donghui Yang, Yun Hu, Shanmei Shen. (2011) Monocyte chemoattractant protein 1–2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population. Clinica Chimica Acta 412:5-6, 466-469
CrossRef94
Norman K. Hollenberg. (2011) Obesity and the Kidney. Current Hypertension Reports 13:1, 11-13
CrossRef95
Juliana CN Chan. (2011) What can we learn from the recent blood glucose lowering megatrials?. Journal of Diabetes Investigation 2:1, 1-5
CrossRef96
C. M. Schooling, L. L. Hui, L. M. Ho, T.-H. Lam, G. M. Leung. (2011) Cohort Profile: 'Children of 1997': a Hong Kong Chinese birth cohort. International Journal of Epidemiology
CrossRef97
Y. M. K. Farag, M. R. Gaballa. (2011) Diabesity: an overview of a rising epidemic. Nephrology Dialysis Transplantation 26:1, 28-35
CrossRef98
Hongfu Zhong, Qionglin Liang, Jianfei Xia, Ping Hu, Yiming Wang, Xiaolin Tong, Guoan Luo. (2011) Simultaneous LC–UV–MS–MS Analysis of Nine Pivotal Metabolites in Human Serum: Application to Studies of Impaired Glucose Tolerance. Chromatographia 73:1-2, 149-155
CrossRef99
Jie Wu, Wen-hua Yan, Ling Qiu, Xin-qi Chen, Xiu-zhi Guo, Wei Wu, Liang-yu Xia, Xu-zhen Qin, Yan-hong Liu, Hai-tao Ding, Shao-mei Han, Cheng-li Xu, Guang-jin Zhu. (2011) High prevalence of coexisting prehypertension and prediabetes among healthy adults in northern and northeastern China. BMC Public Health 11:1, 794
CrossRef100
GA Thomson. (2011) Do current IDF predictions underestimate the true and future burden of diabetes?. Practical Diabetes International 28:1, 5-6
CrossRef101
Angela M Thompson, Yonghong Zhang, Weijun Tong, Tan Xu, Jing Chen, Li Zhao, Tanika N Kelly, Chung-Shiuan Chen, Lydia A Bazzano, Jiang He. (2011) Association of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China. BMC Endocrine Disorders 11:1, 16
CrossRef102
Irfan J. Lodhi, Xiaochao Wei, Clay F. Semenkovich. (2011) Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends in Endocrinology & Metabolism 22:1, 1-8
CrossRef103
Salome A Rebello, Cynthia H Chen, Nasheen Naidoo, Wang Xu, Jeannette Lee, Kee Seng Chia, E Shyong Tai, Rob M van Dam. (2011) Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: a cross-sectional study. Nutrition Journal 10:1, 61
CrossRef104
Jinjuan Peng, Haidong Zou, Weiwei Wang, Jiong Fu, Bingjie Shen, Xuelin Bai, Xun Xu, Xi Zhang. (2011) Implementation and first-year screening results of an ocular telehealth system for diabetic retinopathy in China. BMC Health Services Research 11:1, 250
CrossRef105
(2011) Titration of Insulin Glargine in Patients with Type 2 Diabetes Mellitus in Asia: Physician- Versus Patient-Led? Rationale of the Asian Treat to Target Lantus Study (ATLAS). Diabetes Technology & Therapeutics 13:1, 67-72
CrossRef106
C. Mary Schooling, Chaoqiang Jiang, Weisen Zhang, Tai Hing Lam, Kar Keung Cheng, Gabriel M. Leung. (2011) Adolescent Build and Diabetes: The Guangzhou Biobank Cohort Study. Annals of Epidemiology 21:1, 61-66
CrossRef107
Amina Khambalia, Philayrath Phongsavan, Ben J Smith, Kieren Keke, Li Dan, Andrew Fitzhardinge, Adrian E Bauman. (2011) Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru. BMC Public Health 11:1, 719
CrossRef108
Chaowei Fu, Yue Chen, Fadi Wang, Xuecai Wang, Jiangen Song, Qingwu Jiang. (2011) High prevalence of hyperglycaemia and the impact of high household income in transforming Rural China. BMC Public Health 11:1, 862
CrossRef109
Shu-Qiang Li, Yong Zhou, Yong Wang, Yuan Liu, Dong-Hua Geng, Jin-Gang Liu. (2011) Upregulation of IRS-1 Expression in Goto-Kakizaki Rats Following Roux-en-Y Gastric Bypass Surgery: Resolution of Type 2 Diabetes?. The Tohoku Journal of Experimental Medicine 225:3, 179-186
CrossRef110
Chun Wang, Huiwen Tan, Hongling Yu, Xiangxun Zhang, Lixia Suo, Zhiming Lu, Su Pu, Yerong Yu. (2011) Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patients. Diabetes Research and Clinical Practice 91:1, 67-71
CrossRef111
Wei-Lian Sun, Li-Li Chen, Su-Zhan Zhang, Yan-Min Wu, Yue-Zhong Ren, Guang-Ming Qin. (2011) Inflammatory Cytokines, Adiponectin, Insulin Resistance and Metabolic Control after Periodontal Intervention in Patients with Type 2 Diabetes and Chronic Periodontitis. Internal Medicine 50:15, 1569-1574
CrossRef112
Kyung Yul Hur, Zisun Kim. (2011) The surgical treatment for type 2 diabetes mellitus. Journal of the Korean Medical Association 54:2, 181
CrossRef113
David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea Rita Horvath, M. Sue Kirkman, Ake Lernmark, Boyd E. Metzger, David M. Nathan. (2011) Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Laboratory Medicine Online 1:4, 173
CrossRef114
Yun Gao, Xing-Wu Ran, Xiao-Hua Xie, Hua-Lin Lu, Tao Chen, Yan Ren, Yang Long, Hao-Ming Tian. (2011) Prevalence of overweight and obesity among Chinese Yi nationality: a cross-sectional study. BMC Public Health 11:1, 919
CrossRef115
Robert L. Rosenfield, Brian Bordini. (2010) Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Research 1364, 186-197
CrossRef116
Tao Chen, Yan Ren, Yuanyuan Liu, Yang Long, Xiangxun Zhang, Hongling Yu, Jin Xu, Ting Yu, Haoming Tian. (2010) Serum gamma-glutamyl transferase, ferritin and the risk of type 2 diabetes in women from a Chinese minority. Diabetes Research and Clinical Practice 90:3, 352-357
CrossRef117
Yijun Zhou, Yan Li, Dan Zhang, Jiahe Wang, Hongwu Yang. (2010) Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Research and Clinical Practice 90:3, 261-269
CrossRef118
Xuan XIA, Jianping WENG. (2010) Targeting metabolic syndrome: Candidate natural agents. Journal of Diabetes 2:4, 243-249
CrossRef119
Michele Cecchini, Franco Sassi, Jeremy A Lauer, Yong Y Lee, Veronica Guajardo-Barron, Daniel Chisholm. (2010) Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. The Lancet 376:9754, 1775-1784
CrossRef120
Andrew Plump. (2010) Accelerating the pulse of cardiovascular R&D. Nature Reviews Drug Discovery 9:11, 823-824
CrossRef121
Jianping Weng, Yan Bi. (2010) Diabetes in China: The challenge now. Journal of Diabetes Investigation 1:5, 170-171
CrossRef122
Ming-wei Wang, Qing Liu, Cai-hong Zhou. (2010) Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery. Acta Pharmacologica Sinica 31:9, 1026-1030
CrossRef123
(2010) Journal of Diabetes NEWS. Journal of Diabetes 2:3, 130-135
CrossRef124
Jing-Bo Wang, Yan-Jun Zhang, Yan Zhang, Juan Guan, Li-Ying Chen, Chun-Hua Fu, Hong-Jun Du, Yu Sheng, Li Zhou, Yan-Fang Si, Yan Zhang. (2010) Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus. Acta Diabetologica
CrossRef125
2010. Public Health Aspects of Diabetes. , 16-21.
CrossRef126
(2010) Prevalence of Diabetes among Men and Women in China. New England Journal of Medicine 362:25, 2425-2426
Full Text127
Louis CK Low. (2010) The epidemic of type 2 diabetes mellitus in the Asia-Pacific region. Pediatric Diabetes 11:4, 212-215
CrossRef128
(2010) Evolving R&D for emerging markets. Nature Reviews Drug Discovery 9:6, 417-420
CrossRef129
A.Y.Y. Fong, K.H. Sim. (2010) Picture my heart: Reflections on cardiovascular care in developing countries. CVD Prevention and Control 5:2, 63-64
CrossRef130
Yan Bi, Dalong Zhu, Yali Jing, Yun Hu, Wenhuan Feng, Shanmei Shen, Guoyu Tong, Xujun Shen, Tingting Yu, Dan Song, Donghui Yang. (2010) Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese. Acta Diabetologica
CrossRef131
Felix Cheung. (2010) Public health: The sweet epidemic. Nature China
CrossRef132
J. Ren, Z. C. Pang, W. G. Gao, H. R. Nan, S. J. Wang, L. Zhang, Q. Qiao. (2010) C-Reactive Protein and Gamma-Glutamyltransferase Concentrations in Relation to the Prevalence of Type 2 Diabetes Diagnosed by Glucose or HbA1c Criteria in Chinese Adults in Qingdao, China. Experimental Diabetes Research 2010, 1-8
CrossRef
- Letters
